Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola
Condition: Ebola Virus Disease Intervention: Biological: Ad26.ZEBOV vaccine Sponsors: Universiteit Antwerpen; Johnson & Johnson; Ace Africa; Innovative Medicines Initiative; Coalition for epidemic prepardness innovations; University of Kinshasa Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: African Health | Ebola | Ebola Vaccine | Epidemics | Epidemiology | Research | Study | Vaccines